Innate Pharma (IPHA) Stock Price & Financial Analysis
Innate Pharma Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Innate Pharma
What is the current stock price for IPHA?
As of the latest trading session, IPHA stock trades at $1.76. The 52-week range is $1.17–$2.63, with a day range of $1.74–$1.86.
What is the P/E ratio for IPHA?
The P/E ratio (Price-to-Earnings) for IPHA is shown in the Key Statistics section. This valuation metric helps compare Innate Pharma S.A. to industry peers.
Does IPHA pay dividends?
Innate Pharma does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for IPHA?
Analyst ratings and recommendations for IPHA are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of IPHA?
Innate Pharma's market capitalization is $157.7M, classifying it as a micro-cap company. Innate Pharma operates in the Healthcare sector within the Biotechnology industry.